Küstner, T.; Vogel, J.; Hepp, T.; Forschner, A.; Pfannenberg, C.; Schmidt, H.; Schwenzer, N.F.; Nikolaou, K.; la Fougère, C.; Seith, F.
Development of a Hybrid-Imaging-Based Prognostic Index for Metastasized-Melanoma Patients in Whole-Body 18F-FDG PET/CT and PET/MRI Data. Diagnostics 2022, 12, 2102.
https://doi.org/10.3390/diagnostics12092102
AMA Style
Küstner T, Vogel J, Hepp T, Forschner A, Pfannenberg C, Schmidt H, Schwenzer NF, Nikolaou K, la Fougère C, Seith F.
Development of a Hybrid-Imaging-Based Prognostic Index for Metastasized-Melanoma Patients in Whole-Body 18F-FDG PET/CT and PET/MRI Data. Diagnostics. 2022; 12(9):2102.
https://doi.org/10.3390/diagnostics12092102
Chicago/Turabian Style
Küstner, Thomas, Jonas Vogel, Tobias Hepp, Andrea Forschner, Christina Pfannenberg, Holger Schmidt, Nina F. Schwenzer, Konstantin Nikolaou, Christian la Fougère, and Ferdinand Seith.
2022. "Development of a Hybrid-Imaging-Based Prognostic Index for Metastasized-Melanoma Patients in Whole-Body 18F-FDG PET/CT and PET/MRI Data" Diagnostics 12, no. 9: 2102.
https://doi.org/10.3390/diagnostics12092102
APA Style
Küstner, T., Vogel, J., Hepp, T., Forschner, A., Pfannenberg, C., Schmidt, H., Schwenzer, N. F., Nikolaou, K., la Fougère, C., & Seith, F.
(2022). Development of a Hybrid-Imaging-Based Prognostic Index for Metastasized-Melanoma Patients in Whole-Body 18F-FDG PET/CT and PET/MRI Data. Diagnostics, 12(9), 2102.
https://doi.org/10.3390/diagnostics12092102